share_log

SELLAS Life Sciences Group And 3D Medicines Engaged In Dispute Regarding, Among Other Things, Trigger & Payment Of Milestone Payments; Regarding Failure To Use Commercially Reasonable Best Efforts To Develop GPS In Licensed Territory Particularly China

SELLAS Life Sciences Group And 3D Medicines Engaged In Dispute Regarding, Among Other Things, Trigger & Payment Of Milestone Payments; Regarding Failure To Use Commercially Reasonable Best Efforts To Develop GPS In Licensed Territory Particularly China

SELLAS Life Sciences Group和3D Medicines就里程碑付款的觸發和支付等問題發生爭議;涉及未能盡商業上合理的最大努力在許可地區,尤其是中國,開發全球定位系統
Benzinga ·  2023/12/22 09:11

SELLAS Life Sciences Group And 3D Medicines Engaged In Dispute Regarding, Among Other Things, Trigger & Payment Of Milestone Payments; Regarding Failure To Use Commercially Reasonable Best Efforts To Develop GPS In Licensed Territory Particularly China

SELLAS Life Sciences Group和3D Medicines就里程碑付款的觸發和支付等問題發生爭議;涉及未能盡商業上合理的最大努力在許可地區,尤其是中國,開發全球定位系統

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論